Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 4Phase NA 1Phase 2 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Contracture 2Connective Tissue Diseases 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × xiapex × Clear all
NCT03192020 2026-04-29

DETECT

Tampere University

Phase 4 Active not recruiting
302 enrolled

Connective Tissue Diseases, Contracture, Dupuytren Contracture

NCT02647619 2022-04-26

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

University Hospital, Akershus

Phase 4 Completed
80 enrolled

Dupuytren Contracture

NCT01498640 2017-10-05

Retreatment of Recurrent Dupuytren's Contractures

Endo Pharmaceuticals

Phase 4 Completed
52 enrolled 15 charts

Contracture, Dupuytren Contracture

NCT02476461 2015-06-19

PNFvsxiapex

Oslo University Hospital

Phase 4 Unknown
50 enrolled

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡